BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27056614)

  • 41. Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET.
    Pourfar M; Tang C; Lin T; Dhawan V; Kaplitt MG; Eidelberg D
    J Neurosurg; 2009 Jun; 110(6):1278-82. PubMed ID: 19301972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
    Casteels C; Vermaelen P; Nuyts J; Van Der Linden A; Baekelandt V; Mortelmans L; Bormans G; Van Laere K
    J Nucl Med; 2006 Nov; 47(11):1858-66. PubMed ID: 17079820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
    Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
    J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Widner H; Tetrud J; Rehncrona S; Snow B; Brundin P; Gustavii B; Björklund A; Lindvall O; Langston JW
    N Engl J Med; 1992 Nov; 327(22):1556-63. PubMed ID: 1435882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
    Barrio JR; Huang SC; Melega WP; Yu DC; Hoffman JM; Schneider JS; Satyamurthy N; Mazziotta JC; Phelps ME
    J Neurosci Res; 1990 Dec; 27(4):487-93. PubMed ID: 2127807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model.
    Lerner RP; Bimpisidis Z; Agorastos S; Scherrer S; Dewey SL; Cenci MA; Eidelberg D
    Neurobiol Dis; 2016 Dec; 96():31-37. PubMed ID: 27544483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.
    Wu P; Wang J; Peng S; Ma Y; Zhang H; Guan Y; Zuo C
    Parkinsonism Relat Disord; 2013 Jun; 19(6):622-7. PubMed ID: 23529021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.
    Takagi Y; Takahashi J; Saiki H; Morizane A; Hayashi T; Kishi Y; Fukuda H; Okamoto Y; Koyanagi M; Ideguchi M; Hayashi H; Imazato T; Kawasaki H; Suemori H; Omachi S; Iida H; Itoh N; Nakatsuji N; Sasai Y; Hashimoto N
    J Clin Invest; 2005 Jan; 115(1):102-9. PubMed ID: 15630449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neural repair strategies for Parkinson's disease: insights from primate models.
    Soderstrom K; O'Malley J; Steece-Collier K; Kordower JH
    Cell Transplant; 2006; 15(3):251-65. PubMed ID: 16719060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response.
    Subramanian T; Marchionini D; Potter EM; Cornfeldt ML
    Cell Transplant; 2002; 11(3):207-14. PubMed ID: 12075986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal metabolic networks in atypical parkinsonism.
    Eckert T; Tang C; Ma Y; Brown N; Lin T; Frucht S; Feigin A; Eidelberg D
    Mov Disord; 2008 Apr; 23(5):727-33. PubMed ID: 18186116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of computer-assisted stereotactic transplantation of human retinal pigment epithelium cells in the treatment of Parkinson disease.
    Xue Y; Li X; Pang S; Wang Y; Yao J; Zhou J; Hao P
    J Comput Assist Tomogr; 2013; 37(3):333-7. PubMed ID: 23674001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET.
    Yagi S; Yoshikawa E; Futatsubashi M; Yokokura M; Yoshihara Y; Torizuka T; Ouchi Y
    J Nucl Med; 2010 Aug; 51(8):1250-7. PubMed ID: 20660377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
    J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
    Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease.
    Gonzalez R; Garitaonandia I; Poustovoitov M; Abramihina T; McEntire C; Culp B; Attwood J; Noskov A; Christiansen-Weber T; Khater M; Mora-Castilla S; To C; Crain A; Sherman G; Semechkin A; Laurent LC; Elsworth JD; Sladek J; Snyder EY; Redmond DE; Kern RA
    Cell Transplant; 2016 Nov; 25(11):1945-1966. PubMed ID: 27213850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
    Ko JH; Lee CS; Eidelberg D
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):683-693. PubMed ID: 26980757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.